Indian Pharma will move forward on the wheels of cloud software

We are proud to be featured in Bessemer Venture Capital’s The Rise of SaaS in India 2023 report, highlighting the future of cloud growth in India

The report predicts the Indian pharmaceutical industry will “move forward on the wheels of cloud software.” Clinion has been the leading supplier of cloud computing solutions for clinical trials, and we have been at the forefront of this trend.

We have successfully conducted more than 50 COVID-19 studies and 15 vaccine trials, impacting over 20,000 subjects worldwide. This has given us a deep understanding of how to design, set up, conduct, and complete clinical trials efficiently and effectively.

As aptly noted by Bessemer, “AI and efficiency are key themes for cloud growth in India.” Clinion is committed to using AI and other technologies to improve the efficiency of clinical trials software. Our automation solutions can reduce study time and improve efficiency across the clinical trial process, from eProtocol to Medical Coding to Clinical Study Reports.

We are excited to be a part of the growing cloud computing market in India, and we believe that our solutions can help the pharmaceutical industry accelerate the development of new drugs and therapies.

If you are interested in learning more about Clinion, contact us today.